Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mondelez International (NQ:MDLZ)

62.92 +0.46 (+0.74%)
Streaming Delayed Price Updated: 9:44 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mondelez International

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
22 23 Next >
Obesity Drug Boom, Split Make This Stock a Heavy Bargain
Ozempic users may be losing their appetites for sweets…but Novo Nordisk is one Danish treat that the market may only get hungrier for. 
Via MarketBeat
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior. 
Via Benzinga
Why Mondelez International (MDLZ) Stock Is Nosediving
MONDELEZ INTERNATIONAL INC Common Stock (NASDAQ: MDLZ) shares are trading lower by 5.6% to $61.41 Friday morning. 
Via Benzinga
Retail Resilience: 7 Consumer Goods Stocks to Buy to Weather the Storm
As market storms gather, savvy investors are seeking shelter in consumer goods stocks for their proven reliability and resilience. 
Via InvestorPlace
Looking Into Mondelez International's Recent Short Interest
 
Via Benzinga
5 Analysts Have This to Say About Mondelez International
 
Via Benzinga
Price Over Earnings Overview: Mondelez International
 
Via Benzinga
Big Pharma's Weight Loss Drugs Vs. Snacking Industry: Who Will Prevail?
The rising prevalence of obesity and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Ozempic is triggering concerns among investors about the future of the snacking industry.  
Via Benzinga
Mondelēz International Completes Sale Of Developed Market Gum Business to Perfetti Van Melle
From Mondelez International, Inc.
Via GlobeNewswire
3 Dividend Growth Stocks for Long-Term Returns
Dividend growth stocks can offer investors enticing long-term returns. Let's dive into three exciting options. 
Via InvestorPlace
IPO Wish List: 3 Private Companies I Really Wish Were Public
When it comes to IPOs in 2023, there haven’t been a lot of exciting companies coming to market. Here are three I’d like to see go public. 
Via InvestorPlace
Topics Initial Public Offering
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
 
Via Benzinga
Keurig Dr Pepper Stirs Things Up: Picks Consumer Packaged Goods Veteran Tim Cofer As Next CEO
Keurig Dr Pepper Inc (NASDAQ: KDP) has appointed  
Via Benzinga
2 Reasons to Like the Smucker-Hostess Deal, One Reason to Hate It
J.M. Smucker recently announced its most significant acquisition in its history. The Smucker-Hostess deal isn’t a slam-dunk win. 
Via InvestorPlace
8 Dividend Kings Down 11% or More You’ll Regret Not Buying on the Dip
Dividend Kings are stocks with the longest history of raising dividends and these seven are being discounted by the market 
Via InvestorPlace
Hostess Acquisition, 3.3% Dividend Make J.M. Smucker a Sweet Deal
In light of a market overreaction, patient value investors have a tasty opportunity in J.M. Smucker stock following the company's acquisition of Hostess. 
Via MarketBeat
Mondelēz International’s CoLab Tech Program Announces Start-Ups Selected to Participate in Its Inaugural Class
From Mondelez International, Inc.
Via GlobeNewswire
7 Large-Cap Stocks With Surprisingly Robust Upside Potential
While large-cap stocks to buy tend to be mature enterprises, these stalwarts prove that even they can offer excitement for investors. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
 
Via Benzinga
Mondelez International Inc. (NASDAQ: MDLZ) Highlighted for Surprising Price Action
Via Investor Brand Network
2 Warren Buffett Stocks to Buy Hand Over Fist in September
Warren Buffett's holding company owns stakes in these two blue chip stocks. 
Via The Motley Fool
7 Defensive Stocks to Buy as the Market Suffers Indigestion
With market dynamics sending some worrying signals, investors may want to consider the relative safety of these defensive stocks. 
Via InvestorPlace
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries. 
Via Benzinga
Topics Cannabis Economy
Viridian Chart Of The Week: How Capital Intensive Is Cannabis?
The chart explores the capital intensity of cannabis compared to four other industries thought to be likely suitors for cannabis companies upon federal legalization: Tobacco, Alcoholic Beverages,... 
Via Benzinga
Topics Cannabis
2 Signs Wall Street Is in Full Bull Mode
These moves don't happen when market sentiment is bad. 
Via The Motley Fool
CLIF Partners with Top-Ranked U.S. Tennis Pro Frances Tiafoe to Launch Series of Tennis Clinics Across U.S.
From CLIF
Via Business Wire
3 Buffett Stocks to Buy More of in August
These stocks have the tacit approval of the Oracle of Omaha, given their presence in the Berkshire Hathaway portfolio. 
Via The Motley Fool
7 Stocks to Buy Ahead of a 2024 Recession
Buying these stocks before a possible 2024 recession could save your portfolio from a lot of turmoil. 
Via InvestorPlace
Topics Economy
Mondelēz International to Participate in Barclays Global Consumer Staples Conference on September 6, 2023
From Mondelez International, Inc.
Via GlobeNewswire
Global Packaging Value Chain Leaders Mondelēz International and Amcor Invest in Licella Advanced Recycling in Australia
From Mondelez International, Inc.
Via GlobeNewswire
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.